A US patent for the use of tribes of ORGANOBALANCE GmbH developed for biological indication is new. Such a product would meet in a world market where currently chemical Therapeutics in the value of several sold 100 million euro per year. I am delighted to be able to continue to pursue the outstanding research results, we were able to achieve in our own projects with ORGANOBALANCE GmbH with biological agents, with ORGANOBALANCE medical AG and translate into practical applications. We open previously unknown approaches to therapy”to patients and doctors, Mrs Prof. lang describes their expectations to the new company. On the basis of our biological agents want to and we can often with side effects alternative to today’s drugs, fraught and not always “satisfying effect, develop”, Dr.
Wegener continues and added: for this we have best conditions with our know-how and our patents. ” 5. current projects in addition to the mentioned stomach therapy tracks currently more projects in the area of heavy treatable skin disease. All projects is common, that they, as requested by many patients, should offer alternatives to chemical synthetic therapies on the basis of complete safety matrix and yeast strains. 6 personnel to accomplish its objectives the ORGANOBALANCE GmbH and ORGANOBALANCE medical AG plan the expansion of the staff base of specialized scientists and experts. The companies on the basis of their secured financing, can offer its unique know-how and the patent protection of employment safe workplaces and attractive prospects.
About ORGANOBALANCE medical AG: The ORGANOBALANCE medical AG finances and promotes research and development of novel on specific probiotic cultures based therapy approaches with the aim to create agents and mechanisms for new drugs and medical products and to open up new treatment options for so far not satisfying treat indications.